Every potent medicine may cause harm. Preventing this is one of UMC’s most important objectives. At the Research department, multi-professional teams are working together to develop new methods that empower human experts in detecting new, yet unknown harmful effects of medicines.
If you are studying pharmacovigilance, medicine, pharmacy, nursing or medical/health informatics, and would like to work with improving drug safety in your thesis project, please reach out to us! We have many ongoing projects and are willing to discuss ideas that you have as well. Previous projects can be found here.
Uppsala Monitoring Centre is a dynamic non-profit organization with the mission of improving the safety of medicines throughout the world. By managing and analyzing VigiBase, WHO’s global database of reported potential side effects of medicinal products, consisting of more than 28 million reports from patients and health care professionals in more than 130 countries, UMC has a unique role in detecting the adverse effects of medicines, for which it is recognized internationally.
Who you are
Benefits for you:
Real-world impact – Working for the greater good
Learning organisation – Skilled and curious staff
Flexible work hours – Allows us to be at our best
Uppsala Monitoring Centre (UMC) is a centre for international service and scientific research in the field of pharmacovigilance. We are the WHO Collaborating Centre for International Drug Monitoring, and manage the technical and operational aspects of the WHO Programme for International Drug Monitoring since 1978.
As an independent, non-profit foundation, we support the World Health Organization, regulatory authorities, and other stakeholders who share our vision of advancing medicines safety. Through research and development of new scientific methods, we explore the benefits and harms of medicines for patients, and offer products and services used by health authorities and the pharmaceutical industry worldwide.